These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8108653)

  • 1. Prognostic value of the anatomopathologic variables in head and neck cancer.
    Saba LM
    Rev Paul Med; 1993; 111(4):8-10. PubMed ID: 8108653
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
    Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
    Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent treatment modality for advanced head and neck carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1657-64. PubMed ID: 9757189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Dietl B; Marienhagen J; Schäfer C; Kölbl O
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Head and neck cancer].
    Tukuda M
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1105. PubMed ID: 18686356
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck.
    Barra S; Barzan L; Maione A; Cadelano A; Pin M; Franceschi S; Comoretto R
    Laryngoscope; 1994 Jan; 104(1 Pt 1):95-8. PubMed ID: 8295465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 11. Head and neck cancer emerging strategies: advances and new challenges.
    Awada A; de Castro G
    Curr Opin Oncol; 2009 May; 21(3):191-3. PubMed ID: 19346942
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prognostic factors for head and neck cancer].
    Fujieda S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
    Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
    Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting patients for planned neck dissection after chemoradiotherapy in regionally advanced head and neck cancer.
    Agarwal JP; Mallick I; Ghosh-Laskar S; Gupta T; Budrukkar A; Murthy V
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1121-2; author reply 1122. PubMed ID: 18936367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multicenter survey through a questionnaire on the prognostic value of surgical resection margin in head and neck tumors].
    Cavicchi O; Piccin O; Galasso FS; Marchi C; Cantaroni C; Latini G; Rossi MT; Di Candia G; Caliceti U; Ceroni AR
    Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):413-7. PubMed ID: 11398678
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
    Carlson GW
    Surg Oncol Clin N Am; 1996 Jan; 5(1):65-77. PubMed ID: 8789494
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.
    Tamás L; Kraxner H; Mechtler L; Répássy G; Ribári O; Hirschberg A; Szentkúti G; Járay B; Szentirmay Z
    Anticancer Res; 2000; 20(5C):4031-7. PubMed ID: 11268497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin metastases from a head and neck carcinoma: a prognostic factor?
    Dequanter D; Mboti FB; Lothaire P; Andry G
    B-ENT; 2005; 1(3):113-5. PubMed ID: 16255495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas.
    Fietkau R; Iro H; Tulusan AH; Dressel V; Altendorf-Hofmann A; Sauer R
    Strahlenther Onkol; 1994 Jan; 170(1):13-24. PubMed ID: 8303573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for the malignant triton tumor of the head and neck.
    Terzic A; Bode B; Gratz KW; Stoeckli SJ
    Head Neck; 2009 May; 31(5):679-88. PubMed ID: 19283843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.